Welcome to our dedicated page for DONALDSON Co SEC filings (Ticker: DCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DONALDSON Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DONALDSON Co's regulatory disclosures and financial reporting.
Amy C. Becker, Chief Legal Officer of DONALDSON Co INC (DCI), reported multiple equity transactions dated 10/01/2025. The filing shows 17,000 employee stock options with an exercise price of $82.08 were acquired (reported as Code A) and are recorded as 17,000 shares underlying the option. The option grant note states it vests in three equal annual installments beginning October 1, 2026. Separately, the report shows transfer activity through a benefit plan trust: 1,564 and 8,552 shares are listed as acquired indirectly (Code V) and 47,459 shares are shown as disposed. The form is signed and dated 10/03/2025.
Bart C. Driesen filed an Initial Form 3 reporting ownership in Donaldson Company, Inc. (DCI). He directly owns 5,161 shares of common stock and holds a series of employee stock options exercisable between 09/22/2027 and 10/01/2034 covering 65,200 underlying shares in total. Exercise prices range from $45.43 to $73.17. Several option grants have vesting schedules noted in the filing.
Donaldson Co President Lewis Richard Brent received a grant of 5,942 shares of common stock on September 25, 2025. On the same date, 140 shares were delivered at $80.04 per share to satisfy tax liability. After these events he held 39,779 shares directly, plus additional indirect holdings through benefit plan trusts.
Tod E. Carpenter, Chairman, President and CEO of DONALDSON Co Inc (DCI), reported insider transactions dated 09/25/2025. The filing shows vested/benefit-plan holdings of 11,079 and 11,815 shares held indirectly in benefit plan trusts. On 09/25/2025 he acquired 36,296 shares (reported at $0) and disposed of 17,858 shares at $80.04. The filing lists beneficial ownership figures of 316,557 and 298,699 shares following the reported transactions.
Guillermo Briseno, listed as President of Donaldson Co Inc (DCI), reported a transaction on 09/25/2025. The Form 4 shows he acquired 3,935 shares of common stock, bringing his total beneficial ownership to 29,244 shares. The reported price is listed as $0. The filing was submitted by Amy C. Becker as Attorney-in-Fact and is a single-person Form 4 submission.
Amy C. Becker, Chief Legal Officer of Donaldson Company, reported multiple transactions in DCI stock on 09/25/2025. The Form 4 shows an acquisition of 5,541 shares (reported at $0) and a separate disposition of 2,727 shares at $80.04. After the transactions the filing reports 47,459 shares beneficially owned. The filing also lists indirect holdings of 8,552 and 1,564 shares held by a benefit plan trust. The document is a routine insider transaction report from a company officer.
Donaldson Company, Inc. reports a diversified global filtration business with four regional splits: U.S./Canada 44.2%, EMEA 27.8%, APAC 17.2% and LATAM 10.8%. The company emphasizes three strategic priorities: extend market access, expand technologies and pursue strategic acquisitions. As of Jan 31, 2025, non-affiliate market value was $8,462,489,351 and 115,907,357 shares were outstanding as of Sep 12, 2025. Fiscal 2025 R&D spending was $87.8 million (2.4% of net sales). Backlog within 90 days declined to $552.2 million from $574.7 million. The company recorded $62.0 million of intangible impairment in FY2025 related to bioprocessing ($46.6M Univercells, $15.4M Solaris). During FY2025 it repurchased 4.9 million shares for $333.6 million and maintained a $600 million revolving credit facility with additional accordion capacity.
Guillermo Briseno, identified as an officer (President), reported transactions in Donaldson Company, Inc. (DCI) on 09/03/2025. He exercised 13,500 employee stock options with an exercise price of $28.00, producing 13,500 shares, and simultaneously sold 13,500 common shares at $79.03 per share. After these transactions the filing shows 25,309 shares beneficially owned directly.
The Form 4 notes the options were fully vested and lists an attorney-in-fact signature by Amy C. Becker dated 09/04/2025. The report is a single-person filing and discloses both the non-derivative share sale and the derivative exercise that generated the sold shares.
Form 144 notice for proposed sale of 13,500 common shares valued at $1,066,871.25. The filing states the shares will be sold through Morgan Stanley Smith Barney LLC on the NYSE around 09/03/2025. The shares were acquired on 09/03/2025 by exercise of options under a registered plan and payment was in cash.
Certain identifying details are not provided in the document text supplied: the filer name/CIK and the issuer name/address fields are blank in the extract. The filer represents they are not aware of undisclosed material adverse information and certifies the accuracy of the notice by signature. No securities were reported sold by the filer during the past three months in this filing.
Donaldson Company, Inc. (DCI) Form 4: Director Trudy A. Rautio reported option exercises and share dispositions on 08/28/2025. Ms. Rautio exercised 18,700 options at an exercise price of $28.43 and 13,200 options at $42.26, and then sold those same blocks at $79.96 per share. The transactions left her with 25,621 shares beneficially owned after a reported gift of 3,709 shares. The Form 4 notes the options were fully vested. The filing was signed by Amy C. Becker as attorney-in-fact on 09/02/2025.